Avalon Trust’s West Pharmaceutical WST Stock Holding History

Avalon Trust’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$28.4K	Hold	79	–	–	﹤0.01%	340
2026 Q1	$19.8K	Buy	+79	New	+$19.7K	﹤0.01%	370

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Avalon Trust's WST Position: Q2 2026 in Review

Avalon Trust held its West Pharmaceutical (WST) position steady in Q2 2026 at 79 shares worth $28.4K. The position accounts for ﹤0.01% of the portfolio, ranked #340.

Avalon Trust first reported a position in WST in Q1 2026 and has held it in 2 quarters since. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Avalon Trust held 79 shares of West Pharmaceutical worth $28.4K as of Q2 2026.
Avalon Trust left its West Pharmaceutical share count unchanged in Q2 2026.
West Pharmaceutical made up ﹤0.01% of Avalon Trust's portfolio in Q2 2026, its #340 holding.
Avalon Trust first reported a position in West Pharmaceutical in Q1 2026 and has held it in 2 quarters since.
831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Avalon Trust's 13F filing for Q2 2026, filed 6 Aug 2026.